Ubs Asset Management Americas Inc Pfizer Inc Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Pfizer Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 24,858,131 shares of PFE stock, worth $696 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

24,858,131

Previous 25,723,857 3.37%

Holding current value

$696 Million

Previous $741 Million 6.86%

% of portfolio

0.25%

Previous 0.3%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $22.4 Million - $25.7 Million	-865,726 Reduced 3.37%	24,858,131 $690 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $25.3 Million - $32.9 Million	-968,657 Reduced 3.63%	25,723,857 $741 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $58.3 Million - $68.2 Million	1,817,203 Added 7.31%	26,692,514 $885 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $123 Million - $160 Million	-3,117,981 Reduced 11.14%	24,875,311 $1.01 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $131 Million - $172 Million	3,147,768 Added 12.67%	27,993,292 $1.43 Billion

Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $49.6 Million - $60.6 Million	-1,134,047 Reduced 4.37%	24,845,524 $1.09 Billion
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $84.7 Million - $100 Million	1,820,095 Added 7.53%	25,979,571 $1.36 Billion
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $6.4 Million - $7.94 Million	-139,992 Reduced 0.58%	24,159,476 $1.25 Billion
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $23.6 Million - $35 Million	570,667 Added 2.4%	24,299,468 $1.43 Billion
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $18 Million - $23.1 Million	457,513 Added 1.97%	23,728,801 $1.02 Billion
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $51.4 Million - $58.3 Million	1,432,656 Added 6.56%	23,271,288 $911 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $33.7 Million - $38.1 Million	1,007,711 Added 4.84%	21,838,632 $791 Million
Q4 2020 Mar 01, 2021	BUY	$33.47 - $42.56 $9.15 Million - $11.6 Million	273,326 Added 1.33%	20,830,921 $767 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $71.2 Million - $83.5 Million	-2,242,235 Reduced 9.83%	20,557,595 $716 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $10.5 Million - $12.7 Million	-347,586 Reduced 1.5%	22,799,830 $707 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $65.2 Million - $93.2 Million	2,413,129 Added 11.64%	23,147,416 $717 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $5.67 Million - $6.43 Million	172,120 Added 0.84%	20,734,287 $771 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $21.7 Million - $28.1 Million	-668,096 Reduced 3.15%	20,562,167 $701 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $12.1 Million - $13.6 Million	-327,680 Reduced 1.52%	21,230,263 $0
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $11.4 Million - $12.6 Million	304,692 Added 1.43%	21,557,943 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $9.81 Million - $11.2 Million	255,015 Added 1.21%	21,253,251 $880 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $19.5 Million - $23.6 Million	-564,788 Reduced 2.62%	20,998,236 $0
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $5.83 Million - $6.21 Million	-176,676 Reduced 0.81%	21,563,024 $0
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $58.5 Million - $67.9 Million	1,833,807 Added 9.21%	21,739,700 $0
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $5.19 Million - $5.5 Million	155,942 Added 0.79%	19,905,893 $0
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $612 Million - $674 Million	19,749,951	19,749,951 $0

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Pfizer Inc Transaction History